These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 9812202)

  • 1. The response-to-retention hypothesis of atherogenesis reinforced.
    Williams KJ; Tabas I
    Curr Opin Lipidol; 1998 Oct; 9(5):471-4. PubMed ID: 9812202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis.
    Skålén K; Gustafsson M; Rydberg EK; Hultén LM; Wiklund O; Innerarity TL; Borén J
    Nature; 2002 Jun; 417(6890):750-4. PubMed ID: 12066187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of lipoprotein retention by the extracellular matrix.
    Gustafsson M; Borén J
    Curr Opin Lipidol; 2004 Oct; 15(5):505-14. PubMed ID: 15361785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of extracellular retention of low density lipoproteins in atherosclerosis.
    Borén J; Gustafsson M; Skålén K; Flood C; Innerarity TL
    Curr Opin Lipidol; 2000 Oct; 11(5):451-6. PubMed ID: 11048887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications.
    Tabas I; Williams KJ; Borén J
    Circulation; 2007 Oct; 116(16):1832-44. PubMed ID: 17938300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arterial retention of apolipoprotein B(48)- and B(100)-containing lipoproteins in atherogenesis.
    Proctor SD; Vine DF; Mamo JC
    Curr Opin Lipidol; 2002 Oct; 13(5):461-70. PubMed ID: 12352009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity.
    Borén J; Williams KJ
    Curr Opin Lipidol; 2016 Oct; 27(5):473-83. PubMed ID: 27472409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retention of atherogenic lipoproteins in the artery wall and its role in atherogenesis.
    Fogelstrand P; Borén J
    Nutr Metab Cardiovasc Dis; 2012 Jan; 22(1):1-7. PubMed ID: 22176921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retention of atherogenic lipoproteins in atherogenesis.
    Gustafsson M; Flood C; Jirholt P; Borén J
    Cell Mol Life Sci; 2004 Jan; 61(1):4-9. PubMed ID: 14704849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis.
    Olofsson SO; Borèn J
    J Intern Med; 2005 Nov; 258(5):395-410. PubMed ID: 16238675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein-matrix interactions in macrovascular disease in diabetes.
    Tannock LR; Chait A
    Front Biosci; 2004 May; 9():1728-42. PubMed ID: 14977582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100.
    Véniant MM; Sullivan MA; Kim SK; Ambroziak P; Chu A; Wilson MD; Hellerstein MK; Rudel LL; Walzem RL; Young SG
    J Clin Invest; 2000 Dec; 106(12):1501-10. PubMed ID: 11120757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Why are plasmatic apoB lipoproteins atherogenic? The hypothesis of response to retention].
    Hurt-Camejo E; Camejo G
    Invest Clin; 2001 May; 42 Suppl 1():43-73. PubMed ID: 11416984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingomyelinase converts lipoproteins from apolipoprotein E knockout mice into potent inducers of macrophage foam cell formation.
    Marathe S; Choi Y; Leventhal AR; Tabas I
    Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2607-13. PubMed ID: 11116060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonoxidative modifications of lipoproteins in atherogenesis.
    Tabas I
    Annu Rev Nutr; 1999; 19():123-39. PubMed ID: 10448519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of hepatic lipase to the metabolism of triacylglycerol-rich lipoproteins.
    Zambon A; Bertocco S; Vitturi N; Polentarutti V; Vianello D; Crepaldi G
    Biochem Soc Trans; 2003 Oct; 31(Pt 5):1070-4. PubMed ID: 14505482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis.
    Camejo G; Hurt-Camejo E; Wiklund O; Bondjers G
    Atherosclerosis; 1998 Aug; 139(2):205-22. PubMed ID: 9712326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein heterogeneity and apolipoprotein B metabolism.
    Packard CJ; Shepherd J
    Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3542-56. PubMed ID: 9437204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phospholipase A(2) in vascular disease.
    Hurt-Camejo E; Camejo G; Peilot H; Oörni K; Kovanen P
    Circ Res; 2001 Aug; 89(4):298-304. PubMed ID: 11509445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on the pathogenesis of atherosclerosis.
    Wissler RW
    Am J Med; 1991 Jul; 91(1B):3S-9S. PubMed ID: 1867233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.